PDSB - PDS Biotechnology files for $150 mixed shelf offering
- PDS Biotechnology Corp. ( NASDAQ: PDSB ) has filed for a $150 mixed shelf offering .
- The filing does not necessarily indicate that a sale has begun, or will occur in the future.
- The company intends to use the proceeds for development and commercialization of product candidates and general corporate purposes.
- Separately, PDS Biotechnology ( PDSB ) said it entered into a debt financing agreement led by Horizon Technology Finance Corporation ( HRZN ) for up to $35M.
- Seeking Alpha's Quant Rating views PDS Biotechnology ( PDSB ) as a hold.
For further details see:
PDS Biotechnology files for $150 mixed shelf offering